Results 81 to 90 of about 72,126 (206)

The 2025 ATS/ERS update of the international multidisciplinary classification of the interstitial pneumonias: implications for the pathologist

open access: yesHistopathology, Volume 89, Issue 3, Page 403-425, September 2026.
This review highlights changes relevant to pathologists in the updated multidisciplinary classification of interstitial pneumonias. Changes include expansion beyond idiopathic disease, subclassification as interstitial (fibrotic vs non‐fibrotic) and alveolar filling disorders, expansion to include additional patterns (e.g.
Andrew G Nicholson   +7 more
wiley   +1 more source

Estimation of pulmonary function from time‐resolved dynamic chest radiography using machine learning in patients with respiratory disease

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 8, August 2026.
Abstract Background Pulmonary function tests (PFTs), particularly spirometry, are the reference standard for assessing airflow limitation in respiratory diseases such as chronic obstructive pulmonary disease (COPD) and interstitial pulmonary disease.
Takehiro Shiinoki   +5 more
wiley   +1 more source

Penetrating Chest Trauma With Lung Evisceration, Pneumomediastinum, Pneumocranium, and Brachial Plexus Injury: A Case Report From a Resource‐Limited Setting

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT High‐energy open chest injuries with lung evisceration may be associated with concurrent injuries and serious potential sequelae including pneumocranium, brachial plexus injury, and venous thrombosis. Early resuscitation, adherence to ATLS principles, and coordinated multidisciplinary care are critical for survival and functional outcomes ...
Brian Kasagga   +10 more
wiley   +1 more source

Acute Exacerbation of Chronic Obstructive Pulmonary Disease Immediately After Extubation Following Percutaneous Nephrolithotomy: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT In patients with moderate‐to‐severe COPD, short‐term (1‐day) preoperative respiratory optimization may be insufficient to prevent acute exacerbation after extubation. Prolonged preoperative preparation, meticulous intraoperative lung‐protective ventilation, and a post‐extubation rapid‐response protocol are essential.
Mengyue Gu   +5 more
wiley   +1 more source

miR‐766‐5p Attenuates Cigarette Smoke‐Induced COPD by Targeting MAPK1

open access: yesJournal of Biochemical and Molecular Toxicology, Volume 40, Issue 8, August 2026.
Serum miR‐766‐5p expression is significantly downregulated in COPD patients; miR‐766‐5p is a potential diagnostic biomarker for COPD; miR‐766‐5p serves as an independent protective factor in COPD; miR‐766‐5p significantly alleviates CSE‐induced cellular injury; miR‐766‐5p attenuates COPD progression by targeting MAPK1.
Chang'an Lv   +9 more
wiley   +1 more source

Cigarette Smoke‐Exposed Alveolar Epithelial Cell‐Derived Exosomes Exacerbate Skeletal Muscle Dysfunction Through HDAC2 Signalling

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 4, August 2026.
ABSTRACT Background Skeletal muscle dysfunction (SMD) is a common extrapulmonary complication of chronic obstructive pulmonary disease (COPD). Histone deacetylase 2 (HDAC2) is closely involved in the suppression of inflammatory transcription and is progressively reduced during COPD progression.
Chao Li   +4 more
wiley   +1 more source

SIRT Family: Biological Functions and Therapeutic Targets

open access: yesMedComm, Volume 7, Issue 8, August 2026.
SIRT1–SIRT7 networks from transgenic mice to human‑relevant therapeutic targets. SIRT1–SIRT7 form an isoform‑, organ‑, and disease‑specific regulatory network. Transgenic Sirt1–7 mouse models define central regulatory SIRTs (SIRT1, SIRT3, SIRT6), context‑dependent modifiers (SIRT2, SIRT4, SIRT5, SIRT7), and their key mechanisms and target organs. These
Jia‐Yi Wang   +9 more
wiley   +1 more source

Pulmonary emphysema associated with skin nodules. [PDF]

open access: yesJ Bras Pneumol, 2023
Souza LVS, Souza AS, Marchiori E.
europepmc   +1 more source

Home - About - Disclaimer - Privacy